# MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma

> **NCT00756106** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 15 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** temozolomide
- **OTHER:** Imaging biomarker analysis
- **RADIATION:** Photon Radiation Therapy

## Key facts

- **NCT ID:** NCT00756106
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Funding ended
- **Last updated:** 2020-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756106, "MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT00756106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*